Skip to main content
. Author manuscript; available in PMC: 2025 Mar 4.
Published in final edited form as: J Heart Lung Transplant. 2023 Oct 7;43(3):432–441. doi: 10.1016/j.healun.2023.10.005

Figure 4.

Figure 4

Event-free survival after first PET MPI stratified by MFR and CS-CMVi classification in Kaplan-Meier analyses. Analysis began at 36 months post-transplant to reflect incidence of primary outcome after first positron emission tomography study at 24–36 months. Patients are censored at the time of last follow-up. MFR, myocardial flow reserve. CS-CMVi, clinically significant cytomegalovirus infection.